Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Brander P et al. |
Uniapnean CPAP-hoidon seuranta terveyskeskuksessa.
|
2 |
Cortes J et al. |
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after etc.
|
3 |
Harjama L et al. |
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
|
4 |
Hietanen T et al. |
Effects of Single and Fractionated Irradiation on Natural Killer Cell Populations: Radiobiological Characteristics of Viability and Cytotoxicity In Vitro.
|
5 |
Kankaanranta H et al. |
Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.
|
6 |
Kapanen M et al. |
Effects of remedies made in patient setup process on residual setup errors and margins in head and neck cancer radiotherapy based on 2D image guidance.
|
7 |
Kellokumpu-Lehtinen P. |
Syöpätaudit.
|
8 |
Laaksomaa M et al. |
Determination of the optimal matching position for setup images and minimal setup margins in adjuvant radiotherapy of breast and lymph nodes treated in voluntary deep inhalation breath-hold.
|
9 |
Lehto J. |
Hoitolinjaus.
|
10 |
Lehto J. |
Hoitolinjauksen teko ja sen merkitys.
|
11 |
Lehto J. |
Pitkälle edenneen sairauden hoitosuunnitelma.
|
12 |
Lehto J. |
Saattohoitopäätös.
|
13 |
Lehto J. |
Hengenahdistus.
|
14 |
Lehto J. |
Hengenahdistusoireen arviointi.
|
15 |
Lehto J. |
Hengenahdistuksen syynmukainen hoito.
|
16 |
Lehto J. |
Hengenahdistuksen oireenmukainen lääkehoito.
|
17 |
Lehto J. |
Yskä.
|
18 |
Lehto J. |
Runsaat hengitystie-eritteet.
|
19 |
Lehto J. |
Veriyskä .
|
20 |
Lehto J. |
Hikka.
|
21 |
Lehto J. |
Pleuraneste.
|
22 |
Lehto J. |
Keuhkokasvaimet: oireet ja hoito.
|
23 |
Lehto J. |
Vena cava superior -oireyhtymä.
|
24 |
Lehto J. |
Sydäntamponaatio.
|
25 |
Lehto J. |
Respiratoriset hätätilanteet.
|
26 |
Lehto J. |
Keuhkoahtaumatauti (COPD).
|
27 |
Lehto J. |
Keuhkoahtaumataudin palliatiivisen hoiton tarve.
|
28 |
Lehto J. |
Stabiilin keuhkoahtaumataudin oirekeskeinen hoito.
|
29 |
Lehto J. |
Keuhkoahtaumataudin pahenemisvaihe ja saattohoito.
|
30 |
Lehto J. |
Keuhkofibroosit ja idiopaattinen keuhkofibroosi.
|
31 |
Lehto J. |
Keuhkofibroosipotilaan palliatiivinen hoito ja saattohoito.
|
32 |
Markopoulos C et al. |
Does patient education work in breast cancer? Final results from the global CARIATIDE study.
|
33 |
Skyttä T et al. |
Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.
|
34 |
Skyttä T et al. |
The Concurrent Use of Aromatase Inhibitors and Radiotherapy Induces Echocardiographic Changes in Patients with Breast Cancer .
|
35 |
Sonnenblick A et al. |
Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.
|
36 |
Sousa S et al. |
Human breast cancer cells educate macrophages toward the M2 activation status.
|
37 |
Swain SM et al. |
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
|
38 |
Tanner M, Kellokumpu-Lehtinen P. |
Rintasyöpäpotilaan diagnostiikka ja hoito.
|
39 |
Tuohinen S et al. |
Sädehoidon sydänvaikutukset.
|
40 |
Tuohinen SS et al. |
Early Effects of Adjuvant Breast Cancer Radiotherapy on Right Ventricular Systolic and Diastolic Function .
|
41 |
Vassilev B et al. |
Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells: Potential Mechanisms Contributing to Progression of HER2-Positive Breast Cancers.
|
42 |
Virman J et al. |
VEGFR3 and CD31 as Prognostic Factors in Renal Cell Cancer.
|